The activity of Nef on HIV-1 infectivity

Frontiers in Microbiology

Volumn 5, Issue MAY, 2014, Pages

  Basmaciogullari, Stéphane ^a,b   Pizzato, Massimo ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c UNIVERSITY OF TRENTO   (Italy)

Author keywords

AIDS; Auxiliary proteins; HIV; Nef; Retrovirus infectivity

Indexed keywords

ACTIN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CELL SURFACE PROTEIN; EZRIN; GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEF PROTEIN; POL PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOGENESIS; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; OPEN READING FRAME; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 84904889447     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00232     Document Type: Article

References (166)

1. Agopian, K., Wei, B. L., Garcia, J. V., and Gabuzda, D. (2006). A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J. Virol. 80, 3050-3061. doi: 10.1128/JVI.80.6.3050-3061.2006
2. Ahmad, N., and Venkatesan, S. (1988). Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485. doi: 10.1126/science.3262235
3. Aiken, C. (1997). Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871-5877.
4. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., and Trono, D. (1994). Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864. doi: 10.1016/0092-8674(94)90360-3
5. Aiken, C., and Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048-5056.
6. Alexander, L., Du, Z., Rosenzweig, M., Jung, J. U., and Desrosiers, R. C. (1997). A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J. Virol. 71, 6094-6099.
7. Arganaraz, E. R., Schindler, M., Kirchhoff, F., Cortes, M. J., and Lama, J. (2003). Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J. Biol. Chem. 278, 33912-33919. doi: 10.1074/jbc.M303679200
8. Arold, S., Franken, P., Strub, M. P., Hoh, F., Benichou, S., Benarous, R., et al. (1997). The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5, 1361-1372. doi: 10.1016/S0969-2126(97)00286-4
9. Arya, S. K., and Gallo, R. C. (1986). Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. U.S.A. 83, 2209-2213. doi: 10.1073/pnas.83.7.2209
10. Backer, J. M., Mendola, C. E., Fairhurst, J. L., and Kovesdi, I. (1991). The HIV-1 nef protein does not have guanine nucleotide binding, GTPase, or autophosphorylating activities. AIDS Res. Hum. Retroviruses 7, 1015-1020. doi: 10.1089/aid.1991.7.1015
11. Baur, A. S., Sass, G., Laffert, B., Willbold, D., Cheng-Mayer, C., and Peterlin, B. M. (1997). The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6, 283-291. doi: 10.1016/S1074-7613(00)80331-3
12. Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C., and Peterlin, B. M. (1994). HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384. doi: 10.1016/1074-7613(94)90068-X
13. Bell, I., Ashman, C., Maughan, J., Hooker, E., Cook, F., and Reinhart, T. A. (1998). Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) zeta chain leads to TCR down-modulation. J. Gen. Virol. 79(Pt 11), 2717-2727.
14. Bell, I., Schaefer, T. M., Trible, R. P., Amedee, A., and Reinhart, T. A. (2001). Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef. Virology 283, 148-158. doi: 10.1006/viro.2001.0872
15. Benichou, S., Liu, L. X., Erdtmann, L., Selig, L., and Benarous, R. (1997). Use of the two-hybrid system to identify cellular partners of the HIV1 Nef protein. Res. Virol. 148, 71-73. doi: 10.1016/S0923-2516(97)81918-8
16. Benson, R. E., Sanfridson, A., Ottinger, J. S., Doyle, C., and Cullen, B. R. (1993). Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177, 1561-1566. doi: 10.1084/jem.177.6.1561
17. Bentham, M., Mazaleyrat, S., and Harris, M. (2006). Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87, 563-571. doi: 10.1099/vir.0.81200-0
18. Berro, R., De La Fuente, C., Klase, Z., Kehn, K., Parvin, L., Pumfery, A., et al. (2007). Identifying the membrane proteome of HIV-1 latently infected cells. J. Biol. Chem. 282, 8207-8218. doi: 10.1074/jbc.M606324200
19. Blagoveshchenskaya, A. D., Thomas, L., Feliciangeli, S. F., Hung, C. H., and Thomas, G. (2002). HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111, 853-866. doi: 10.1016/S0092-8674(02)01162-5
20. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., et al. (2008). Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926. doi: 10.1126/science.1152725
21. Bregnard, C., Zamborlini, A., Leduc, M., Chafey, P., Camoin, L., Saib, A., et al. (2013). Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J. Virol. 87, 3729-3740. doi: 10.1128/JVI.02477-12
22. Bresnahan, P. A., Yonemoto, W., Ferrell, S., Williams-Herman, D., Geleziunas, R., and Greene, W. C. (1998). A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr. Biol. 8, 1235-1238. doi: 10.1016/S0960-9822(07)00517-9
23. Breuer, S., Gerlach, H., Kolaric, B., Urbanke, C., Opitz, N., and Geyer, M. (2006). Biochemical indication for myristoylation-dependent conformational changes in HIV-1 Nef. Biochemistry 45, 2339-2349. doi: 10.1021/bi052052c
24. Brugger, B., Krautkramer, E., Tibroni, N., Munte, C. E., Rauch, S., Leibrecht, I., et al. (2007). Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 4:70. doi: 10.1186/1742-4690-4-70
25. Brun, S., Solignat, M., Gay, B., Bernard, E., Chaloin, L., Fenard, D., et al. (2008). VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability. Retrovirology 5:57. doi: 10.1186/1742-4690-5-57
26. Bukovsky, A. A., Dorfman, T., Weimann, A., and Gottlinger, H. G. (1997). Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71, 1013-1018.
27. Campbell, E. M., Nunez, R., and Hope, T. J. (2004). Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78, 5745-5755. doi: 10.1128/JVI.78.11.5745-5755.2004
28. Carl, S., Greenough, T. C., Krumbiegel, M., Greenberg, M., Skowronski, J., Sullivan, J. L., et al. (2001). Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J. Virol. 75, 3657-3665. doi: 10.1128/JVI.75.8.3657-3665.2001
29. Cavrois, M., Neidleman, J., Yonemoto, W., Fenard, D., and Greene, W. C. (2004). HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. Virology 328, 36-44. doi: 10.1016/j.virol.2004.07.015
30. Chazal, N., Singer, G., Aiken, C., Hammarskjold, M. L., and Rekosh, D. (2001). Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J. Virol. 75, 4014-4018. doi: 10.1128/JVI.75.8.4014-4018.2001
31. Chen, B. K., Gandhi, R. T., and Baltimore, D. (1996). CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70, 6044-6053.
32. Chen, Y. L., Trono, D., and Camaur, D. (1998). The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity. J. Virol. 72, 3178-3184.
33. Chowers, M. Y., Pandori, M. W., Spina, C. A., Richman, D. D., and Guatelli, J. C. (1995). The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212, 451-457. doi: 10.1006/viro.1995.1502
34. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J., Richman, D. D., and Guatelli, J. C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914.
35. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D., and Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401. doi: 10.1038/34929
36. Cortes, M. J., Wong-Staal, F., and Lama, J. (2002). Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. J. Biol. Chem. 277, 1770-1779. doi: 10.1074/jbc.M109807200
37. Craig, H. M., Pandori, M. W., and Guatelli, J. C. (1998). Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 95, 11229-11234. doi: 10.1073/pnas.95.19.11229
38. Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767. doi: 10.1038/312763a0
39. Day, J. R., Munk, C., and Guatelli, J. C. (2004). The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity. J. Virol. 78, 1069-1079. doi: 10.1128/JVI.78.3.1069-1079.2004
40. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., et al. (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991. doi: 10.1126/science.270.5238.988
41. de Ronde, A., Klaver, B., Keulen, W., Smit, L., and Goudsmit, J. (1992). Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology 188, 391-395. doi: 10.1016/0042-6822(92)90772-H
42. Dikeakos, J. D., Thomas, L., Kwon, G., Elferich, J., Shinde, U., and Thomas, G. (2012). An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I. Mol. Biol. Cell 23, 2184-2197. doi: 10.1091/mbc.E11-11-0928 mbc.E11-11-0928
43. Dorfman, T., Popova, E., Pizzato, M., and Gottlinger, H. G. (2002). Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. J. Virol. 76, 6857-6862. doi: 10.1128/JVI.76.13.6857-6862.2002
44. Fackler, O. T., Luo, W., Geyer, M., Alberts, A. S., and Peterlin, B. M. (1999). Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3, 729-739. doi: 10.1016/S1097-2765(01)80005-8
45. Faure, J., Stalder, R., Borel, C., Sobo, K., Piguet, V., Demaurex, N., et al. (2004). ARF1 regulates Nef-induced CD4 degradation. Curr. Biol. 14, 1056-1064. doi: 10.1016/j.cub.2004.06.021
46. Forshey, B. M., and Aiken, C. (2003). Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex. J. Virol. 77, 4409-4414. doi: 10.1128/JVI.77.7.4409-4414.2003
47. Franchini, G., Robert-Guroff, M., Wong-Staal, F., Ghrayeb, J., Kato, I., Chang, T. W., et al. (1986). Expression of the protein encoded by the 3′ open reading frame of human T-cell lymphotropic virus type III in bacteria: demonstration of its immunoreactivity with human sera. Proc. Natl. Acad. Sci. U.S.A. 83, 5282-5285. doi: 10.1073/pnas.83.14.5282
48. Fujii, Y., Otake, K., Fujita, Y., Yamamoto, N., Nagai, Y., Tashiro, M., et al. (1996). Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett. 395, 257-261. doi: 10.1016/0014-5793(96)01048-4
49. Fujita, K., Omura, S., and Silver, J. (1997). Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J. Gen. Virol. 78(Pt 3), 619-625.
50. Garcia, J. V., and Miller, A. D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511. doi: 10.1038/350508a0
51. Glushakova, S., Munch, J., Carl, S., Greenough, T. C., Sullivan, J. L., Margolis, L., et al. (2001). CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 75, 10113-10117. doi: 10.1128/JVI.75.21.10113-10117.2001
52. Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D., and Greene, W. C. (1995). Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69, 4112-4121.
53. Greenberg, M. E., Bronson, S., Lock, M., Neumann, M., Pavlakis, G. N., and Skowronski, J. (1997). Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16, 6964-6976. doi: 10.1093/emboj/16.23.6964
54. Grzesiek, S., Bax, A., Clore, G. M., Gronenborn, A. M., Hu, J. S., Kaufman, J., et al. (1996). The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 3, 340-345. doi: 10.1038/nsb0496-340
55. Grzesiek, S., Bax, A., Hu, J. S., Kaufman, J., Palmer, I., Stahl, S. J., et al. (1997). Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci. 6, 1248-1263. doi: 10.1002/pro.5560060613
56. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., et al. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269. doi: 10.1038/330266a0
57. Haller, C., Tibroni, N., Rudolph, J. M., Grosse, R., and Fackler, O. T. (2011). Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse. Eur. J. Cell Biol. 90, 913-921. doi: 10.1016/j.ejcb.2010.09.010
58. Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R., and Greene, W. C. (1989). Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc. Natl. Acad. Sci. U.S.A. 86, 9549-9553. doi: 10.1073/pnas.86.23.9549
59. Hua, J., and Cullen, B. R. (1997). Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4. J. Virol. 71, 6742-6748.
60. Hulme, A. E., Perez, O., and Hope, T. J. (2011). Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc. Natl. Acad. Sci. U.S.A. 108, 9975-9980. doi: 10.1073/pnas.1014522108
61. Jager, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., Mcgovern, K. E., Clarke, S. C., et al. (2012). Global landscape of HIV-human protein complexes. Nature 481, 365-370. doi: 10.1038/nature10719
62. Janvier, K., Craig, H., Le Gall, S., Benarous, R., Guatelli, J., Schwartz, O., et al. (2001). Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. J. Virol. 75, 3971-3976. doi: 10.1128/JVI.75.8.3971-3976.2001
63. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., et al. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5:e1000429. doi: 10.1371/journal.ppat.1000429
64. Johnson, J. E., Rodgers, W., and Rose, J. K. (1998). A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Virology 251, 244-252. doi: 10.1006/viro.1998.9429
65. Jolly, C., Kashefi, K., Hollinshead, M., and Sattentau, Q. J. (2004). HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199, 283-293. doi: 10.1084/jem.20030648
66. Jorgenson, R. L., Vogt, V. M., and Johnson, M. C. (2009). Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J. Virol. 83, 4060-4067. doi: 10.1128/JVI.02425-08
67. Kammula, E. C., Motter, J., Gorgels, A., Jonas, E., Hoffmann, S., and Willbold, D. (2012). Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins. PLoS ONE 7:e51578. doi: 10.1371/journal.pone.0051578
68. Kestler, H. W. III, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., et al. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662. doi: 10.1016/0092-8674(91)90097-I
69. Khan, I. H., Sawai, E. T., Antonio, E., Weber, C. J., Mandell, C. P., Montbriand, P., et al. (1998). Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J. Virol. 72, 5820-5830.
70. Khan, M., Garcia-Barrio, M., and Powell, M. D. (2001). Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription. J. Virol. 75, 12081-12087. doi: 10.1128/JVI.75.24.12081-12087.2001
71. Kim, S., Ikeuchi, K., Byrn, R., Groopman, J., and Baltimore, D. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86, 9544-9548. doi: 10.1073/pnas.86.23.9544
72. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R. C. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232. doi: 10.1056/NEJM199501263320405
73. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., et al. (1984). T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768. doi: 10.1038/312767a0
74. Kohleisen, B., Neumann, M., Herrmann, R., Brack-Werner, R., Krohn, K. J., Ovod, V., et al. (1992). Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 6, 1427-1436. doi: 10.1097/00002030-199212000-00002
75. Konig, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M., Irelan, J. T., et al. (2008). Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60. doi: 10.1016/j.cell.2008.07.032
76. Kramer-Hammerle, S., Hahn, A., Brack-Werner, R., and Werner, T. (2005). Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses. Gene 358, 31-38. doi: 10.1016/j.gene.2005.05.011
77. Kramer, G., Moerland, P. D., Jeeninga, R. E., Vlietstra, W. J., Ringrose, J. H., Byrman, C., et al. (2012). Proteomic analysis of HIV-T cell interaction: an update. Front. Microbiol. 3:240. doi: 10.3389/fmicb.2012.00240
78. Laguette, N., Benichou, S., and Basmaciogullari, S. (2009a). HIV-1 Nef Incorporation into Virions does not Increase Infectivity. J. Virol. 83, 1093-1104. doi: 10.1128/JVI.01633-08
79. Laguette, N., Bregnard, C., Bouchet, J., Benmerah, A., Benichou, S., and Basmaciogullari, S. (2009b). Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of the p56lck kinase. J. Virol. 83, 7117-7128. doi: 10.1128/JVI.01648-08
80. Lai, R. P., Yan, J., Heeney, J., Mcclure, M. O., Gottlinger, H., Luban, J., et al. (2011). Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. PLoS Pathog. 7:e1002442. doi: 10.1371/journal.ppat.1002442
81. Lama, J., Mangasarian, A., and Trono, D. (1999). Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9, 622-631. doi: 10.1016/S0960-9822(99)80284-X
82. Landi, A., Iannucci, V., Nuffel, A. V., Meuwissen, P., and Verhasselt, B. (2011). One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. Curr. HIV Res. 9, 496-504. doi: 10.2174/157016211798842116
83. Larsen, J. E., Massol, R. H., Nieland, T. J., and Kirchhausen, T. (2004). HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity. Mol. Biol. Cell 15, 323-331. doi: 10.1091/mbc.E03-08-0578
84. Lee, C. H., Saksela, K., Mirza, U. A., Chait, B. T., and Kuriyan, J. (1996). Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85, 931-942. doi: 10.1016/S0092-8674(00)81276-3
85. Little, S. J., Riggs, N. L., Chowers, M. Y., Fitch, N. J., Richman, D. D., Spina, C. A., et al. (1994). Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1. Virology 205, 578-582. doi: 10.1006/viro.1994.1683
86. Lock, M., Greenberg, M. E., Iafrate, A. J., Swigut, T., Muench, J., Kirchhoff, F., et al. (1999). Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis. EMBO J. 18, 2722-2733. doi: 10.1093/emboj/18.10.2722
87. Lubben, N. B., Sahlender, D. A., Motley, A. M., Lehner, P. J., Benaroch, P., and Robinson, M. S. (2007). HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2. Mol. Biol. Cell 18, 3351-3365. doi: 10.1091/mbc.E07-03-0218
88. Luciw, P. A., Cheng-Mayer, C., and Levy, J. A. (1987). Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc. Natl. Acad. Sci. U.S.A. 84, 1434-1438. doi: 10.1073/pnas.84.5.1434
89. Lundquist, C. A., Tobiume, M., Zhou, J., Unutmaz, D., and Aiken, C. (2002). Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J. Virol. 76, 4625-4633. doi: 10.1128/JVI.76.9.4625-4633.2002
90. Lundquist, C. A., Zhou, J., and Aiken, C. (2004). Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication. J. Virol. 78, 6287-6296. doi: 10.1128/JVI.78.12.6287-6296.2004
91. Luo, T., Douglas, J. L., Livingston, R. L., and Garcia, J. V. (1998). Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems. Virology 241, 224-233. doi: 10.1006/viro.1997.8966
92. Magadan, J. G., Perez-Victoria, F. J., Sougrat, R., Ye, Y., Strebel, K., and Bonifacino, J. S. (2010). Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 6:e1000869. doi: 10.1371/journal.ppat.1000869
93. Malbec, M., Sourisseau, M., Guivel-Benhassine, F., Porrot, F., Blanchet, F., Schwartz, O., et al. (2013). HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer. Retrovirology 10, 80. doi: 10.1186/1742-4690-10-80
94. Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V., et al. (1998). A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565-574. doi: 10.1016/S1097-2765(00)80056-8
95. Miller, M. D., Warmerdam, M. T., Ferrell, S. S., Benitez, R., and Greene, W. C. (1997). Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity. Virology 234, 215-225. doi: 10.1006/viro.1997.8641
96. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., and Feinberg, M. B. (1994). The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113. doi: 10.1084/jem.179.1.101
97. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B., and Greene, W. C. (1995). Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69, 579-584.
98. Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V., and Melikyan, G. B. (2009). HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137, 433-444. doi: 10.1016/j.cell.2009.02.046
99. Mukerji, J., Olivieri, K. C., Misra, V., Agopian, K. A., and Gabuzda, D. (2012). Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology 9, 33. doi: 10.1186/1742-4690-9-33
100. Munch, J., Janardhan, A., Stolte, N., Stahl-Hennig, C., Ten Haaft, P., Heeney, J. L., et al. (2002). T-cell receptor: CD3 down-regulation is a selected in vivo function of simian immunodeficiency virus Nef but is not sufficient for effective viral replication in rhesus macaques. J. Virol. 76, 12360-12364. doi: 10.1128/JVI.76.23.12360-12364.2002
101. Munch, J., Rajan, D., Schindler, M., Specht, A., Rucker, E., Novembre, F. J., et al. (2007). Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J. Virol. 81, 13852-13864. doi: 10.1128/JVI.00904-07
102. Murakami, T., and Freed, E. O. (2000). Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74, 3548-3554. doi: 10.1128/JVI.74.8.3548-3554.2000
103. Muranyi, W., Malkusch, S., Muller, B., Heilemann, M., and Krausslich, H. G. (2013). Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog. 9:e1003198. doi: 10.1371/journal.ppat.1003198
104. Niederman, T. M., Thielan, B. J., and Ratner, L. (1989). Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc. Natl. Acad. Sci. U.S.A. 86, 1128-1132. doi: 10.1073/pnas.86.4.1128
105. Noviello, C. M., Benichou, S., and Guatelli, J. C. (2008). Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J. Virol. 82, 1249-1258. doi: 10.1128/JVI.00660-07
106. Ono, A., Huang, M., and Freed, E. O. (1997). Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 71, 4409-4418.
107. Ono, A., Orenstein, J. M., and Freed, E. O. (2000). Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74, 2855-2866. doi: 10.1128/JVI.74.6.2855-2866.2000
108. Pandori, M. W., Fitch, N. J., Craig, H. M., Richman, D. D., Spina, C. A., and Guatelli, J. C. (1996). Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70, 4283-4290.
109. Papkalla, A., Munch, J., Otto, C., and Kirchhoff, F. (2002). Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. J. Virol. 76, 8455-8459. doi: 10.1128/JVI.76.16.8455-8459.2002
110. Piguet, V., Chen, Y. L., Mangasarian, A., Foti, M., Carpentier, J. L., and Trono, D. (1998). Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 17, 2472-2481. doi: 10.1093/emboj/17.9.2472
111. Piguet, V., Gu, F., Foti, M., Demaurex, N., Gruenberg, J., Carpentier, J. L., et al. (1999). Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97, 63-73. doi: 10.1016/S0092-8674(00)80715-1
112. Piguet, V., Wan, L., Borel, C., Mangasarian, A., Demaurex, N., Thomas, G., et al. (2000). HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2, 163-167. doi: 10.1038/35004038
113. Pizzato, M. (2010). MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. Proc. Natl. Acad. Sci. U.S.A. 107, 9364-9369. doi: 10.1073/pnas.1001554107
114. Pizzato, M., Helander, A., Popova, E., Calistri, A., Zamborlini, A., Palu, G., et al. (2007). Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc. Natl. Acad. Sci. U.S.A. 104, 6812-6817. doi: 10.1073/pnas.0607622104
115. Pizzato, M., Popova, E., and Gottlinger, H. G. (2008). Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. J. Virol. 82, 10811-10819. doi: 10.1128/JVI.01150-08
116. Qi, M., and Aiken, C. (2008). Nef enhances HIV-1 infectivity via association with the virus assembly complex. Virology 373, 287-297. doi: 10.1016/j.virol.2007.12.001
117. Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., et al. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284. doi: 10.1038/313277a0
118. Rauch, S., Pulkkinen, K., Saksela, K., and Fackler, O. T. (2008). Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J. Virol. 82, 2918-2929. doi: 10.1128/JVI.02185-07
119. Reil, H., Bukovsky, A. A., Gelderblom, H. R., and Gottlinger, H. G. (1998). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708. doi: 10.1093/emboj/17.9.2699
120. Renkema, G. H., Manninen, A., Mann, D. A., Harris, M., and Saksela, K. (1999). Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9, 1407-1410. doi: 10.1016/S0960-9822(00)80086-X
121. Rhee, S. S., and Marsh, J. W. (1994). Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68, 5156-5163.
122. Ringrose, J. H., Jeeninga, R. E., Berkhout, B., and Speijer, D. (2008). Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J. Virol. 82, 4320-4330. doi: 10.1128/JVI.01819-07
123. Roeth, J. F., Williams, M., Kasper, M. R., Filzen, T. M., and Collins, K. L. (2004). HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell Biol. 167, 903-913. doi: 10.1083/jcb.200407031
124. Roy, N. H., Chan, J., Lambele, M., and Thali, M. (2013). Clustering and mobility of HIV-1 Env at viral assembly sites predict its propensity to induce cell-cell fusion. J. Virol. 87, 7516-7525. doi: 10.1128/JVI.00790-13
125. Saksela, K., Cheng, G., and Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14, 484-491.
126. Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L., et al. (1985). Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227, 484-492. doi: 10.1126/science.2578227
127. Sanfridson, A., Cullen, B. R., and Doyle, C. (1994). The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. J. Biol. Chem. 269, 3917-3920.
128. Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C. (1994). Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 1539-1543. doi: 10.1073/pnas.91.4.1539
129. Sawai, E. T., Khan, I. H., Montbriand, P. M., Peterlin, B. M., Cheng-Mayer, C., and Luciw, P. A. (1996). Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr. Biol. 6, 1519-1527. doi: 10.1016/S0960-9822(96)00757-9
130. Schaefer, T. M., Bell, I., Fallert, B. A., and Reinhart, T. A. (2000). The T-cell receptor zeta chain contains two homologous domains with which simian immunodeficiency virus Nef interacts and mediates down-modulation. J. Virol. 74, 3273-3283. doi: 10.1128/JVI.74.7.3273-3283.2000
131. Schaeffer, E., Geleziunas, R., and Greene, W. C. (2001). Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J. Virol. 75, 2993-3000. doi: 10.1128/JVI.75.6.2993-3000.2001
132. Schiavoni, I., Trapp, S., Santarcangelo, A. C., Piacentini, V., Pugliese, K., Baur, A., et al. (2004). HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity. J. Biol. Chem. 279, 22996-23006. doi: 10.1074/jbc.M312453200
133. Schindler, M., Munch, J., Kutsch, O., Li, H., Santiago, M. L., Bibollet-Ruche, F., et al. (2006). Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125, 1055-1067. doi: 10.1016/j.cell.2006.04.033
134. Schindler, M., Wurfl, S., Benaroch, P., Greenough, T. C., Daniels, R., Easterbrook, P., et al. (2003). Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77, 10548-10556. doi: 10.1128/JVI.77.19.10548-10556.2003
135. Schrager, J. A., and Marsh, J. W. (1999). HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 96, 8167-8172. doi: 10.1073/pnas.96.14.8167
136. Schubert, U., Anton, L. C., Bacik, I., Cox, J. H., Bour, S., Bennink, J. R., et al. (1998). CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72, 2280-2288.
137. Schwartz, O., Dautry-Varsat, A., Goud, B., Marechal, V., Subtil, A., Heard, J. M., et al. (1995a). Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69, 528-533.
138. Schwartz, O., Marechal, V., Danos, O., and Heard, J. M. (1995b). Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053-4059.
139. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F., and Heard, J. M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338-342. doi: 10.1038/nm0396-338
140. Simmons, A., Aluvihare, V., and Mcmichael, A. (2001). Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14, 763-777. doi: 10.1016/S1074-7613(01)00158-3
141. Sourisseau, M., Sol-Foulon, N., Porrot, F., Blanchet, F., and Schwartz, O. (2007). Inefficient human immunodeficiency virus replication in mobile lymphocytes. J. Virol. 81, 1000-1012. doi: 10.1128/JVI.01629-06
142. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C., and Richman, D. D. (1994). The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123. doi: 10.1084/jem.179.1.115
143. Stolp, B., Reichman-Fried, M., Abraham, L., Pan, X., Giese, S. I., Hannemann, S., et al. (2009). HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe 6, 174-186. doi: 10.1016/j.chom.2009.06.004
144. Swigut, T., Shohdy, N., and Skowronski, J. (2001). Mechanism for down-regulation of CD28 by Nef. EMBO J. 20, 1593-1604. doi: 10.1093/emboj/20.7.1593
145. Swingler, S., Gallay, P., Camaur, D., Song, J., Abo, A., and Trono, D. (1997). The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71, 4372-4377.
146. Tedbury, P. R., Ablan, S. D., and Freed, E. O. (2013). Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog. 9:e1003739. doi: 10.1371/journal.ppat.1003739
147. Terwilliger, E. F., Langhoff, E., Gabuzda, D., Zazopoulos, E., and Haseltine, W. A. (1991). Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 88, 10971-10975. doi: 10.1073/pnas.88.23.10971
148. Tobiume, M., Lineberger, J. E., Lundquist, C. A., Miller, M. D., and Aiken, C. (2003). Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J. Virol. 77, 10645-10650. doi: 10.1128/JVI.77.19.10645-10650.2003
149. Tobiume, M., Takahoko, M., Tatsumi, M., and Matsuda, M. (2001). Establishment of a MAGI-derived indicator cell line that detects the Nef enhancement of HIV-1 infectivity with high sensitivity. J. Virol. Methods 97, 151-158. doi: 10.1016/S0166-0934(01)00349-4
150. Tokunaga, K., Kojima, A., Kurata, T., Ikuta, K., Akari, H., Koyama, A. H., et al. (1998). Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent. J. Gen. Virol. 79(Pt 10), 2447-2453.
151. Usami, Y., and Gottlinger, H. (2013). HIV-1 Nef Responsiveness Is Determined by Env Variable Regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep. 5, 802-812. doi: 10.1016/j.celrep.2013.09.028
152. Usami, Y., Popov, S., and Gottlinger, H. G. (2014). The Nef-Like Effect of Murine Leukemia Virus Glycosylated Gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex. J. Virol. 88, 3443-3454. doi: 10.1128/JVI.01933-13
153. van't Wout, A. B., Swain, J. V., Schindler, M., Rao, U., Pathmajeyan, M. S., Mullins, J. I., et al. (2005). Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J. Virol. 79, 10053-10058. doi: 10.1128/JVI.79.15.10053-10058.2005
154. van Wilgenburg, B., Moore, M. D., James, W. S., and Cowley, S. A. (2014). The Productive Entry Pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4. PLoS ONE 9:e86071. doi: 10.1371/journal.pone.0086071
155. Wang, J. K., Kiyokawa, E., Verdin, E., and Trono, D. (2000). The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl. Acad. Sci. U.S.A. 97, 394-399. doi: 10.1073/pnas.97.1.394
156. Welker, R., Harris, M., Cardel, B., and Krausslich, H. G. (1998). Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J. Virol. 72, 8833-8840.
157. Welker, R., Kottler, H., Kalbitzer, H. R., and Krausslich, H. G. (1996). Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219, 228-236. doi: 10.1006/viro.1996.0240
158. Wildum, S., Schindler, M., Munch, J., and Kirchhoff, F. (2006). Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 80, 8047-8059. doi: 10.1128/JVI.00252-06
159. Williams, M., Roeth, J. F., Kasper, M. R., Filzen, T. M., and Collins, K. L. (2005). Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J. Virol. 79, 632-636. doi: 10.1128/JVI.79.1.632-636.2005
160. Williams, M., Roeth, J. F., Kasper, M. R., Fleis, R. I., Przybycin, C. G., and Collins, K. L. (2002). Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76, 12173-12184. doi: 10.1128/JVI.76.23.12173-12184.2002
161. Xu, X. N., Laffert, B., Screaton, G. R., Kraft, M., Wolf, D., Kolanus, W., et al. (1999). Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189, 1489-1496. doi: 10.1084/jem.189.9.1489
162. Xu, X. N., Screaton, G. R., Gotch, F. M., Dong, T., Tan, R., Almond, N., et al. (1997). Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186, 7-16. doi: 10.1084/jem.186.1.7
163. Yang, Y., Fricke, T., and Diaz-Griffero, F. (2013). Inhibition of reverse transcriptase activity increases stability of the HIV-1 core. J. Virol. 87, 683-687. doi: 10.1128/JVI.01228-12
164. Zazopoulos, E., and Haseltine, W. A. (1993). Effect of nef alleles on replication of human immunodeficiency virus type 1. Virology 194, 20-27. doi: 10.1006/viro.1993.1230
165. Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C., et al. (2008). Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504. doi: 10.1016/j.chom.2008.10.004
166. Zhou, J., and Aiken, C. (2001). Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope. J. Virol. 75, 5851-5859. doi: 10.1128/JVI.75.13.5851-5859.2001